Emcure Pharmaceuticals (EMCURE) Share Price Falls 3.41% to Rs 1,926.10
- September 16, 2026
- Posted by: Harsh Piplani
- Category: News
Emcure Pharmaceuticals Share Price fell today, with the stock closing at Rs 1,926.10 after a 3.41% decline. The company’s market capitalisation stood at Rs 37,501.05 crore, placing Emcure Pharmaceuticals in the Large Cap category. Based on the supplied data, the session is relevant because it captures a clear same-day share price decline, but it does not establish a company-specific catalyst. In other words, Emcure Pharmaceuticals Stock News today is defined by the price move itself, the day’s range and the current valuation snapshot rather than a stated event trigger. For readers tracking Emcure Pharmaceuticals Share Price Today, the key next checks are the day’s range, the gap versus the previous close and how the current multiples compare with Healthcare peers on Univest.
From a reporting standpoint, Univest is presenting the fall as verified market data first: the stock moved lower after an opening above the prior close, and the price action settled near the day’s lower end. That makes Emcure Pharmaceuticals Share Price Fall a live market update worth watching alongside fundamentals and sector comparisons.
Emcure Pharmaceuticals (EMCURE) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,926.1 |
| Previous Close | Rs 1,994.15 |
| Today's Move | -Rs 68.05 (-3.41%) |
| Open | Rs 2,007.15 |
| High | Rs 2,014.55 |
| Low | Rs 1,903.7 |
| Turnover | Rs 1.96 crore |
| Market Capitalisation | Rs 37,501.05 crore |
| Market Cap Category | Large Cap |
Emcure Pharmaceuticals Share Price Today reflected a weaker close than the previous session. The stock opened at Rs 2,007.15, moved to a day high of Rs 2,014.55 and a day low of Rs 1,903.70, before ending at Rs 1,926.10. Against the previous close of Rs 1,994.15, the share price declined by Rs 68.05, or 3.41%. The full day range shows that the stock traded below the opening price by the close and finished closer to the lower end of the session band than to the high.
Turnover stood at Rs 1.96 crore, which is the exact factual value supplied for the session. With a market cap of Rs 37,501.05 crore and the Large Cap tag, Emcure Pharmaceuticals Stock Performance is being viewed in the context of a sizeable listed healthcare company rather than a small business event. The price move is therefore relevant for both short-term market followers and readers looking at Emcure Pharmaceuticals Share Price Live. The supplied data confirms the decline, but it does not establish a company-specific reason for the move. That makes the next useful lens the company’s financial profile and relative valuation.
Emcure Pharmaceuticals (EMCURE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 37,501.05 crore |
| P/E Ratio | 37.41x |
| P/B Ratio | 7.23x |
| ROE | 20.09% |
| ROCE | 25.25% |
| EPS | Rs 53.31 |
| Book Value Per Share | Rs 275.72 |
| Dividend Yield | 0.18% |
EPS is Rs 53.31, which represents earnings attributable to each share, while book value is Rs 275.72 per share, showing the accounting net worth behind each share. Dividend yield is 0.18%, which is historical/current data rather than a payout promise. In this setting, Emcure Pharmaceuticals Share Price sits on top of a fundamentals profile that has meaningful returns on capital and equity, but also a valuation that can be compared carefully with the broader Healthcare set on Univest. For readers scanning Emcure Pharmaceuticals Latest News, these are the figures that matter most when separating the day’s price fall from the company’s underlying reported numbers. The next section places those figures in the context of ownership, though no ownership snapshot is supplied here, so the focus remains on sector and peer benchmarks.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 37.41x |
| Benchmark Median P/E | 31.74x |
| Benchmark Average P/E | 47.98x |
| Benchmark P/E Range | 3.29x to 683.37x |
| Company P/B Ratio | 7.23x |
| Benchmark Median P/B | 3.02x |
| Benchmark Average P/B | 4.44x |
| Company ROE | 20.09% |
| Benchmark Median ROE | 11.78% |
| Benchmark Average ROE | 11.19% |
| Company ROCE | 25.25% |
| Benchmark Median ROCE | 13.65% |
| Benchmark Average ROCE | 13.65% |
| Company Market Capitalisation | Rs 37,501.05 crore |
| Benchmark Median Market Cap | Rs 750.5 crore |
| Benchmark Average Market Cap | Rs 14,144.11 crore |
Within Healthcare and the Pharmaceuticals & Drugs industry, Emcure Pharmaceuticals Share Price can be compared against a same-industry benchmark scope of 200 companies. In that benchmark set, the company’s P/E of 37.41 sits above the median P/E of 31.74 but below the benchmark average of 47.98. Its P/B of 7.23 is also above the benchmark median P/B of 3.02 and above the benchmark average of 4.44.
On profitability, ROE of 20.09% is above the benchmark median ROE of 11.78% and above the benchmark average of 11.19%. ROCE of 25.25% is also above the benchmark median and average of 13.65%. The benchmark market-cap median is Rs 750.5 crore, while the average is Rs 14,144.11 crore, which places Emcure Pharmaceuticals Market Cap well above both reference points. For sector and industry readers following Emcure Pharmaceuticals Stock Analysis, the numbers show a company that is priced above the central industry valuation measures while also reporting stronger return ratios than the benchmark medians. That mix is important for anyone comparing Emcure Pharmaceuticals Share Price with other Healthcare names on Univest.
The sector context also helps explain why the share price fall should be read as a daily market event rather than an isolated valuation verdict. The stock’s current ratios need to be viewed beside the industry’s range, especially because the benchmark includes a wide spread from P/E 3.29 to 683.37 and P/B from -11.17 to 26.92. Such spreads mean company-specific reading matters more than broad labels.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,957.5 | 36.4 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,47,576 | 83.41 | 13.81 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,233.01 | 84.58 | 20.55 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,11,670.55 | 24.29 | 4.07 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,10,272.68 | 32.62 | 3.13 | 11.83 | 16 |
Emcure Pharmaceuticals Share Price can be read against listed Healthcare peers using the supplied peer set. Compared with Sun Pharmaceutical Industries, Emcure has a higher P/E at 37.41 versus 36.4, a higher P/B at 7.23 versus 5.09, higher ROE at 20.09% versus 14.85%, and higher ROCE at 25.25% versus 19.11%. Against Divi’s Laboratories, Emcure’s P/E and P/B are lower than 83.41 and 13.81, while its ROE and ROCE are higher than 16.19% and 21.51%.
Versus Torrent Pharmaceuticals, Emcure’s P/E and P/B are lower than 84.58 and 20.55, and its ROE and ROCE are lower than 26.76% but higher than 19.27% on ROCE? Actually the supplied figures show Emcure’s ROCE at 25.25% is above Torrent’s 19.27%, while ROE is lower than Torrent’s 26.76%. Against Zydus Lifesciences, Emcure’s P/E and P/B are higher than 24.29 and 4.07, while ROE and ROCE are slightly higher than 19.69% and 21.39%. This peer frame shows that Emcure Pharmaceuticals Stock News is not only about a one-day decline; it is also about where the stock sits on valuation and return metrics inside the Healthcare pack.
Why Investors Are Watching Emcure Pharmaceuticals
- Emcure Pharmaceuticals Share Price fell 3.41% to Rs 1,926.10 in today’s session.
- The stock opened at Rs 2,007.15, touched Rs 2,014.55, and saw a low of Rs 1,903.70.
- Market capitalisation stood at Rs 37,501.05 crore, with the company classified as Large Cap.
- P/E is 37.41, P/B is 7.23, ROE is 20.09% and ROCE is 25.25%.
- In the Healthcare and Pharmaceuticals & Drugs peer set, Emcure Pharmaceuticals Share Price can be compared with Sun Pharma, Divi’s, Torrent, Zydus, Cipla, Laurus Labs, Dr. Reddy’s, Aurobindo Pharma, Lupin and Mankind Pharma.
About Emcure Pharmaceuticals
Emcure Pharmaceuticals operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies it as a Large Cap company with a market capitalisation of Rs 37,501.05 crore. For Emcure Pharmaceuticals Share News, the most reliable context available here is the company’s classification, valuation and return ratios rather than a detailed business description. This keeps Emcure Pharmaceuticals Share Price reporting factual and anchored to verified market data. Readers tracking Emcure Pharmaceuticals Company News on Univest can use the sector and peer framework to place the stock’s daily move into a broader listed-pharma context.
Track Emcure Pharmaceuticals Share Price on Univest
Use Emcure Pharmaceuticals (EMCURE) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Emcure Pharmaceuticals Share Price on Univest for live price updates, company ratios, shareholding pattern, 52-week levels, market insights and peer comparison. Univest brings together Emcure Pharmaceuticals Stock Analysis, Emcure Pharmaceuticals Fundamental Analysis and Emcure Pharmaceuticals Latest News in one place for quick reference.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Emcure Pharmaceuticals Share Price fall today?
Ans. The supplied data confirms a 3.41% decline in Emcure Pharmaceuticals Share Price to Rs 1,926.10. It does not establish a company-specific catalyst, so the verified report stays to the day’s price action.
What was Emcure Pharmaceuticals Share Price today?
Ans. Emcure Pharmaceuticals Share Price today was Rs 1,926.10, down Rs 68.05 from the previous close of Rs 1,994.15. The stock opened at Rs 2,007.15 and traded between Rs 1,903.70 and Rs 2,014.55.
What is the market capitalisation of Emcure Pharmaceuticals?
Ans. Emcure Pharmaceuticals had a market capitalisation of Rs 37,501.05 crore in the supplied data. It is classified as a Large Cap company, which is factual size context for readers following the share price fall.
How does Emcure Pharmaceuticals compare on valuation?
Ans. Emcure Pharmaceuticals Share Price is backed by a P/E ratio of 37.41 and a P/B ratio of 7.23. In the same-industry benchmark, both are above the median values of 31.74 and 3.02.
What do ROE and ROCE show for Emcure Pharmaceuticals?
Ans. Emcure Pharmaceuticals reports ROE of 20.09% and ROCE of 25.25%. Both are above the same-industry benchmark medians and averages, which gives useful context to Emcure Pharmaceuticals Share Price. ROE stands at 20.09%.
How does Emcure Pharmaceuticals compare with peers?
Ans. In the supplied peer set, Emcure Pharmaceuticals Share Price sits below Sun Pharma on market cap but above Zydus on P/E and P/B. Its ROE and ROCE also compare closely with listed Healthcare peers.
